Tacent Projects Ltd

Authorised Capital Increased to ₹22 crore; Preferential Issue Planned

Authorised Capital: ₹22 crore
Proposed Equity Shares: 34,00,000

Reader Takeaway: Capital expansion and fundraise indicate growth potential; watch for equity dilution and valuation.

What just happened

Tacent Projects Limited's Board of Directors has approved a significant capital restructuring. This includes increasing the company's authorised share capital from ₹10 crore to ₹22 crore, subject to member approval.

The company has also received in-principle approval for a preferential issuance of 34,00,000 equity shares and 1,15,87,750 fully convertible warrants.

Why this matters

This move signals Tacent Projects' intent to fund future growth or expansion plans. The capital increase and issuance are crucial steps for potentially larger projects or acquisitions.

Existing shareholders should note the potential for equity dilution. The valuation and pricing of these new securities will be key factors in determining the impact on their holdings.

The backstory

This is a proactive step by Tacent Projects to ensure it has the financial flexibility for its strategic objectives. The company is preparing for a phase that requires substantial capital.

What changes now

The proposed changes are subject to shareholder and regulatory approvals. A board meeting on August 11, 2026, will finalize the terms, including issue price, relevant date, and allottees.

Mr. Neeraj Chaudhary has been appointed as an Additional Director (Executive), effective July 31, 2026, to support the company's growth strategy.

Risks to watch

Equity dilution is a primary concern, given the significant number of shares and warrants proposed for issuance. Investors must monitor the pricing to understand the dilution impact.

Execution risk is also present, as the capital increase and fundraising are contingent on securing necessary approvals from members and relevant authorities.

Investor Takeaway

Tacent Projects is preparing for growth, but shareholders need to assess the potential dilution and the final terms of the preferential issuance. The upcoming board meeting on August 11, 2026, will provide crucial details.